newsfilter
← Latest News
Business Wire·

Frequency Therapeutics to Participate in Upcoming March 2022 Investor Conferences

Frequency Therapeutics, Inc. (NASDAQ:FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person's innate regenerative potential to restore function, today announced that Chief Executive Officer David L.